PTK2 and liver cancer: Moreover, an in vitro and in vivo study, by Chung et al. [64], reported that Lipocalin enhanced migration and invasion abilities in liver cancer cells by promoting reduction of E-cadherin levels and increasing MET and FAK protein phosphorylation.